DrugPatentWatch Database Preview
Biologic Drugs With Dosage Form: POWDER;IV (INFUSION)
» See Plans and Pricing
Details for Dosage Type: POWDER;IV (INFUSION)
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Ridgeback Biotherapeutics | EBANGA | ansuvimab-zykl | POWDER;IV (INFUSION) | 761172 | 001 | 2020-12-21 | Start Trial | RX | Orphan | |||
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |